| Clip Of FDA Safety and Innovation Act, Part 2 This clip, title, and description were not created by C-SPAN.

User-Created Clip
November 15, 2013
Rep. Engel questions FDA's Dr. Janet Woodcock Mentions rare disease, accelerated approval, Duchenne muscular dystrophy; Sarepta Therapeutics & eteplirsen, patient advocacy, establishing natural history of rare diseases

Report profane or abusive content

People in this video

  • Eliot Engel U.S. Representative [D] New York
  • Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research

Hosting Organization

More Videos From

House Energy & Commerce Committee: Implementation of FDA Safety & Innovation Act

More information about

Rep. Engel questions FDA's Dr. Janet Woodcock

179 Views
Program ID:
316262-2
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
Purchase a DVD or Download

Rep. Engel questions FDA's Dr. Janet Woodcock

  • MP4 video - Low
    Price:
    Free
  • MP4 video - Standard
    Price:
    $2.99
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video